These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26554325)

  • 21. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.
    Murrough JW; Soleimani L; DeWilde KE; Collins KA; Lapidus KA; Iacoviello BM; Lener M; Kautz M; Kim J; Stern JB; Price RB; Perez AM; Brallier JW; Rodriguez GJ; Goodman WK; Iosifescu DV; Charney DS
    Psychol Med; 2015 Dec; 45(16):3571-80. PubMed ID: 26266877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration of ketamine for unipolar and bipolar depression.
    Kraus C; Rabl U; Vanicek T; Carlberg L; Popovic A; Spies M; Bartova L; Gryglewski G; Papageorgiou K; Lanzenberger R; Willeit M; Winkler D; Rybakowski JK; Kasper S
    Int J Psychiatry Clin Pract; 2017 Mar; 21(1):2-12. PubMed ID: 28097909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness.
    Thomas RK; Baker G; Lind J; Dursun S
    J Psychopharmacol; 2018 Oct; 32(10):1110-1117. PubMed ID: 30182797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials.
    Fornaro M; Stubbs B; De Berardis D; Perna G; Valchera A; Veronese N; Solmi M; Ganança L
    Int J Mol Sci; 2016 Feb; 17(2):241. PubMed ID: 26891297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketamine and depression: a narrative review.
    Corriger A; Pickering G
    Drug Des Devel Ther; 2019; 13():3051-3067. PubMed ID: 31695324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis.
    Xiong J; Lipsitz O; Chen-Li D; Rosenblat JD; Rodrigues NB; Carvalho I; Lui LMW; Gill H; Narsi F; Mansur RB; Lee Y; McIntyre RS
    J Psychiatr Res; 2021 Feb; 134():57-68. PubMed ID: 33360864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of ketamine gargle in reducing postoperative sore throat in patients undergoing airway instrumentation: a systematic review.
    Mayhood J; Cress K
    JBI Database System Rev Implement Rep; 2015 Sep; 13(9):244-78. PubMed ID: 26470672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence.
    Rodrigues NB; McIntyre RS; Lipsitz O; Cha DS; Lee Y; Gill H; Majeed A; Phan L; Nasri F; Ho R; Lin K; Subramaniapillai M; Kratiuk K; Mansur RB; Rosenblat JD
    J Affect Disord; 2020 Nov; 276():570-575. PubMed ID: 32871688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis.
    Bahji A; Ermacora D; Stephenson C; Hawken ER; Vazquez G
    Can J Psychiatry; 2021 Mar; 66(3):274-288. PubMed ID: 33174452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of suicidal depression with ketamine in rapid cycling bipolar disorder.
    Sampath H; Sharma I; Dutta S
    Asia Pac Psychiatry; 2016 Mar; 8(1):98-101. PubMed ID: 26871425
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis.
    Rodolico A; Cutrufelli P; Di Francesco A; Aguglia A; Catania G; Concerto C; Cuomo A; Fagiolini A; Lanza G; Mineo L; Natale A; Rapisarda L; Petralia A; Signorelli MS; Aguglia E
    Front Psychiatry; 2024; 15():1325399. PubMed ID: 38362031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
    Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C
    J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Update on the Efficacy of Single and Serial Intravenous Ketamine Infusions and Esketamine for Bipolar Depression: A Systematic Review and Meta-Analysis.
    Nunez NA; Joseph B; Kumar R; Douka I; Miola A; Prokop LJ; Mickey BJ; Singh B
    Brain Sci; 2023 Dec; 13(12):. PubMed ID: 38137120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Update on the Efficacy and Tolerability of Oral Ketamine for Major Depression: A Systematic Review and Meta-Analysis.
    Nuñez NA; Joseph B; Pahwa M; Seshadri A; Prokop LJ; Kung S; Schak KM; Vande Voort JL; Frye MA; Singh B
    Psychopharmacol Bull; 2020 Sep; 50(4):137-163. PubMed ID: 33012876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action of ketamine.
    Stahl SM
    CNS Spectr; 2013 Aug; 18(4):171-4. PubMed ID: 23866089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuation phase intravenous ketamine in adults with treatment-resistant depression.
    Vande Voort JL; Morgan RJ; Kung S; Rasmussen KG; Rico J; Palmer BA; Schak KM; Tye SJ; Ritter MJ; Frye MA; Bobo WV
    J Affect Disord; 2016 Dec; 206():300-304. PubMed ID: 27656788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
    Papakostas GI; Martinson MA; Fava M; Iovieno N
    J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ketamine treatment on suicidal ideation: a qualitative study of patients' accounts following treatment for depression in a UK ketamine clinic.
    Lascelles K; Marzano L; Brand F; Trueman H; McShane R; Hawton K
    BMJ Open; 2019 Aug; 9(8):e029108. PubMed ID: 31420388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.